Cartesian Therapeutics
RNAC
RNAC
46 hedge funds and large institutions have $124M invested in Cartesian Therapeutics in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+3
Holders Change %
+6.98%
% of All Funds
1.15%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
11
Increased
14
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SRF
Silver Rock Financial
Los Angeles,
California
|
$9.68M |
2 |
BlackRock
New York
|
$2.99M |
3 |
DM
Deerfield Management
New York
|
$15.2M |
4 |
Millennium Management
New York
|
$3.4M |
5 |
UBS Group
Zurich,
Switzerland
|
$1.02M |